A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
Clinical trial NCT06512051 · RECRUITING
Trial details
- NCT number
- NCT06512051
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-30
- Primary completion
- 2026-10-01
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.